ChromaDex Corporation

ChromaDex Corporation

Compare this stock

CDXC Stock Report Card

$

VolatilityTechnicalsSentimentProfitPerformanceEarningsAnalyst Price Targets

34%

Performance

Score:

10/100

CDXC returned -23.46% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

Score:

88/100

2 analysts offer 12-month price targets for CDXC. Together, they have an average target of 0, the most optimistic target put CDXC at 0 within 12-months and the most pessimistic has CDXC at 0.

Sentiment

Score:

73/100

CDXC had a bullish sentiment score of 72.97% across Twitter and StockTwits over the last 12 months. It had an average of 2.80 posts, 1.24 comments, and 2.68 likes per day.

Technicals

Score:

10/100

CDXC receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

Earnings

Score:

10/100

CDXC has missed earnings 6 times in the last 20 quarters.

Profit

Score:

10/100

Out of the last 20 quarters, CDXC has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

Score:

46/100

CDXC has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.

ChromaDex Corporation Summary

Nasdaq / CDXC
Healthcare
Biotechnology
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.